In the News: Sino-US Scientific Cooperation; AstraZeneca Splits Its China Operation?; and Italy Limits Influence of Chinese Company

The U.S. government is debating whether to renew the U.S.-China Science and Technology Agreement; AstraZeneca plans to break up its business in China and list it separately in Hong Kong; the Italian government applies Golden Power regulations to limit the influence of China's Sinochem on tyremaker Pirelli